BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 17910069)

  • 1. Assembly of the oncogenic DNA-binding complex LMO2-Ldb1-TAL1-E12.
    Ryan DP; Duncan JL; Lee C; Kuchel PW; Matthews JM
    Proteins; 2008 Mar; 70(4):1461-74. PubMed ID: 17910069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins.
    Wadman IA; Osada H; Grütz GG; Agulnick AD; Westphal H; Forster A; Rabbitts TH
    EMBO J; 1997 Jun; 16(11):3145-57. PubMed ID: 9214632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the key LMO2-binding determinants on Ldb1.
    Ryan DP; Sunde M; Kwan AH; Marianayagam NJ; Nancarrow AL; Vanden Hoven RN; Thompson LS; Baca M; Mackay JP; Visvader JE; Matthews JM
    J Mol Biol; 2006 May; 359(1):66-75. PubMed ID: 16616188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The TAL1/Scl basic helix-loop-helix protein blocks myogenic differentiation and E-box dependent transactivation.
    Hofmann TJ; Cole MD
    Oncogene; 1996 Aug; 13(3):617-24. PubMed ID: 8760303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decoding hematopoietic specificity in the helix-loop-helix domain of the transcription factor SCL/Tal-1.
    Schlaeger TM; Schuh A; Flitter S; Fisher A; Mikkola H; Orkin SH; Vyas P; Porcher C
    Mol Cell Biol; 2004 Sep; 24(17):7491-502. PubMed ID: 15314159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia.
    Baer R
    Semin Cancer Biol; 1993 Dec; 4(6):341-7. PubMed ID: 8142619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of DNA sequence in the binding specificity of synthetic basic-helix-loop-helix domains.
    Beltran AC; Dawson PE; Gottesfeld JM
    Chembiochem; 2005 Jan; 6(1):104-13. PubMed ID: 15593070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of the leukemia oncogene LMO2: implications for the assembly of a hematopoietic transcription factor complex.
    El Omari K; Hoosdally SJ; Tuladhar K; Karia D; Vyas P; Patient R; Porcher C; Mancini EJ
    Blood; 2011 Feb; 117(7):2146-56. PubMed ID: 21076045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A DNA-binding mutant of TAL1 cooperates with LMO2 to cause T cell leukemia in mice.
    Draheim KM; Hermance N; Yang Y; Arous E; Calvo J; Kelliher MA
    Oncogene; 2011 Mar; 30(10):1252-60. PubMed ID: 21057528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the LMO4 gene encoding an interaction partner of the LIM-binding protein LDB1/NLI1: a candidate for displacement by LMO proteins in T cell acute leukaemia.
    Grutz G; Forster A; Rabbitts TH
    Oncogene; 1998 Nov; 17(21):2799-803. PubMed ID: 9840944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAL-1/SCL and its partners E47 and LMO2 up-regulate VE-cadherin expression in endothelial cells.
    Deleuze V; Chalhoub E; El-Hajj R; Dohet C; Le Clech M; Couraud PO; Huber P; Mathieu D
    Mol Cell Biol; 2007 Apr; 27(7):2687-97. PubMed ID: 17242194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LIM-only protein Lmo2 forms a protein complex with erythroid transcription factor GATA-1.
    Osada H; Grutz GG; Axelson H; Forster A; Rabbitts TH
    Leukemia; 1997 Apr; 11 Suppl 3():307-12. PubMed ID: 9209374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Products of the TAL2 oncogene in leukemic T cells: bHLH phosphoproteins with DNA-binding activity.
    Xia Y; Hwang LY; Cobb MH; Baer R
    Oncogene; 1994 May; 9(5):1437-46. PubMed ID: 8152805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of in vivo complexes between the TAL1 and E2A polypeptides of leukemic T cells.
    Hsu HL; Wadman I; Baer R
    Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3181-5. PubMed ID: 8159721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The LIM-domain binding protein Ldb1 and its partner LMO2 act as negative regulators of erythroid differentiation.
    Visvader JE; Mao X; Fujiwara Y; Hahm K; Orkin SH
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13707-12. PubMed ID: 9391090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice.
    Larson RC; Lavenir I; Larson TA; Baer R; Warren AJ; Wadman I; Nottage K; Rabbitts TH
    EMBO J; 1996 Mar; 15(5):1021-7. PubMed ID: 8605871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins.
    Hsu HL; Huang L; Tsan JT; Funk W; Wright WE; Hu JS; Kingston RE; Baer R
    Mol Cell Biol; 1994 Feb; 14(2):1256-65. PubMed ID: 8289805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MyoD-E12 heterodimers and MyoD-MyoD homodimers are equally stable.
    Maleki SJ; Royer CA; Hurlburt BK
    Biochemistry; 1997 Jun; 36(22):6762-7. PubMed ID: 9184158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of a novel GTP binding protein, DRG, with TAL oncogenic proteins.
    Mahajan MA; Park ST; Sun XH
    Oncogene; 1996 Jun; 12(11):2343-50. PubMed ID: 8649774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Lim-only protein LMO2 acts as a positive regulator of erythroid differentiation.
    Hansson A; Zetterblad J; van Duren C; Axelson H; Jönsson JI
    Biochem Biophys Res Commun; 2007 Dec; 364(3):675-81. PubMed ID: 17964543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.